Altamira Therapeutics Ltd. (CYTOF): 20-F filed Apr 30, 2025

Form type

20-F

Filing date

Apr 30, 2025

Accession number

0001213900-25-037199

Filer

Altamira Therapeutics Ltd. (CIK 1601936)